Methods for Determination of Cost-Benefit Relations for Medicines in Germany

被引：3
作者：
von der Schulenburg, J. -M. Graf [1 ]
Vauth, C. [1 ]
Mittendorf, T. [1 ]
Greiner, W. [2 ]
机构：
[1] Leibniz Univ Hannover, Wirtschaftswissensch Fak, Inst Versicherungsbetriebslehre, Konigsworther Pl 1, D-30167 Hannover, Germany
[2] Univ Bielefeld, Fak Gesundheitswissensch, Bielefeld, Germany
来源：
GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT | 2007年 / 12卷
关键词：
D O I：
10.1055/s-2007-963108
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S3 / S25
页数：23
相关论文
共 68 条
  • [1] Akehurst R, 2000, PHARMACOECONOMICS, V17, P443
  • [2] Cost-of-illness studies - A review of current methods
    Akobundu, Ebere
    Ju, Jing
    Blatt, Lisa
    Mullins, C. Daniel
    [J]. PHARMACOECONOMICS, 2006, 24 (09) : 869 - 890
  • [3] Disability-adjusted life years: a critical review
    Anand, S
    Hanson, K
    [J]. JOURNAL OF HEALTH ECONOMICS, 1997, 16 (06) : 685 - 702
  • [4] Arnesen T, 2000, LEPROSY REV, V71, P123
  • [5] Opening the debate on DALYs
    Barker, C
    Green, A
    [J]. HEALTH POLICY AND PLANNING, 1996, 11 (02) : 179 - 183
  • [6] Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535
  • [7] Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-lite) instrument from the SF-6D
    Brazier, JE
    Kolotkin, RL
    Crosby, RD
    Williams, GR
    [J]. VALUE IN HEALTH, 2004, 7 (04) : 490 - 498
  • [8] Bren Linda, 2006, FDA Consum, V40, P26
  • [9] Probabilistic analysis of cost-effectiveness models: Statistical representation of parameter uncertainty
    Briggs, A
    [J]. VALUE IN HEALTH, 2005, 8 (01) : 1 - 2
  • [10] An introduction to Markov modelling for economic evaluation
    Briggs, A
    Sculpher, M
    [J]. PHARMACOECONOMICS, 1998, 13 (04) : 397 - 409
1234567